Why We Report Our Outcomes

Neurocore’s purpose is to ensure that everyone who comes to us for help leaves better than when they came. That’s why Neurocore conducts a comprehensive initial assessment and provides a free post-program assessment to everyone who completes the program.

Pre and post analysis and reporting of outcomes is not the norm in mental health, but Neurocore believes that this should be the standard by which all providers are measured. This also holds us accountable every day to ensure we’re delivering the best possible care and service we can provide to our clients. Importantly, it helps prospective clients understand what previous clients have experienced so they can make an informed decision about our program and their choice of care.

What Our Outcomes Mean

The statistics on our website represent the outcome results of every Neurocore client who has completed the post program assessment after 30 sessions dating back to August 15, 2015 who had either clinical or borderline depression, anxiety, and/or ADHD. The only individuals excluded in the analysis were Neurocore employees and their family members to eliminate any concerns about potential bias. The analysis compares the changes in symptoms reported by clients at the initial assessment to those after the completion of the program.

Why We Use Symptom Rating Scales

Neurocore collects numerous pieces of data to measure and track client progress, but symptom rating scales are the current gold standard for measuring improvement in mental and behavioral health. To date, there are no biomarker measures for conditions like ADHD, anxiety, or depression. Neurocore uses the Achenbach System of Empirically Based Assessment (ASEBA) to measure symptoms.

The ASEBA is widely used in areas including mental health services, schools, medical settings, child and family services, and public health agencies. It’s supported by extensive research on service needs and outcomes, diagnosis, prevalence of problems, medical conditions, and treatment efficacy. The ASEBA is also correlated to the Diagnostic and Statistical Manual of Mental Disorders (DSM–5), which is recognized as the authoritative manual and is used in the field of Psychiatry and Psychology to define and classify mental disorders in order to improve diagnosis, treatment, and research. The ASEBA can relate directly to DSM-5 diagnostic categories by using the DSM-oriented scales for scoring ASEBA forms.

What Does “Noticeable Reduction of Symptoms” Mean

Minimal clinically important differences (MCID) is an established measurement that is intended to reflect changes in a clinical intervention that are meaningful for the patient. Our reported outcomes in this category represent the percentage of clients who completed the post program assessment after 30 sessions and reported symptoms reductions that exceeded the MCID established for the ASEBA. We describe this as a noticeable reduction of symptoms.

What Does “No Longer Met Symptomatic Thresholds” Mean

The ASEBA stratifies clients into one of three categories for a condition – normal, borderline and clinical. Our reported outcomes in this category represent the percentage of clients who started out in the borderline or clinical range based on their self-reported symptoms, and after completing 30 sessions ended up in the normal category. We describe this as no longer meeting symptomatic thresholds for the originally presenting condition.

While there may be information on the Neurocore website relating to certain conditions, should a medical condition exist, promptly see your own physician or health provider. Neurocore does not offer medical diagnosis or treatment advice. Neurocore makes no claims that it can cure any conditions, including any conditions referenced on its website or in print materials, including ADHD, anxiety, autism, depression, traumatic brain injury, post-traumatic stress disorder, migraines, headaches, stress, sleep disorders, Alzheimer’s and dementia. If you take prescription medications for any of these conditions, you should consult with your physician before discontinuing use of such medications.